NCT03190174 2025-02-17Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersSarcoma Oncology Research Center, LLCPhase 1/2 Completed34 enrolled 14 charts
NCT05061537 2024-04-12Study of PF-07263689 in Participants With Selected Advanced Solid TumorsPfizerPhase 1 Terminated13 enrolled 16 charts